MonumenTAL-8
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Near Add Your Location
Sorting 9 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Not currently accepting
- Accepting patients
Thomas Jefferson University Hospital
Philadelphia, PA
- Accepting patients
- Accepting patients
Holden Comprehensive Cancer Center - University of Iowa
University of Iowa Hospitals and Clinics
Iowa City, IA
- Accepting patients
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
- Not yet accepting
- Not yet accepting
- Not currently accepting
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
- Not currently accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.